The global market for Pharmaceutical Impurity Analysis Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Pharmaceutical Impurity Analysis Service is a quality testing service for pharmaceutical products. This service is designed to detect possible harmful impurities in pharmaceutical products to ensure the safety and effectiveness of the products. This service is very important for quality control and supervision of pharmaceutical companies and helps ensure the safety and effectiveness of patients" medications.

North American market for Pharmaceutical Impurity Analysis Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pharmaceutical Impurity Analysis Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Pharmaceutical Impurity Analysis Service in Pharmaceutical Industry is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Pharmaceutical Impurity Analysis Service include Intertek, Creative Proteomics, Emery Pharma, Agilent, Vimta, Alfa Chemistry, Eurofins, Alera Labs, Impact Analytical, Leeder Analytical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Impurity Analysis Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Impurity Analysis Service.

The Pharmaceutical Impurity Analysis Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Impurity Analysis Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical Impurity Analysis Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmaceutical Impurity Analysis Service Market Report

Report Metric	Details
Report Name	Pharmaceutical Impurity Analysis Service Market
Segment by Type	Organic Impurity Analysis Inorganic Impurity Analysis Residual Solvent Analysis Others
Segment by Application	Pharmaceutical Industry Agriculture Biotechnology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Intertek, Creative Proteomics, Emery Pharma, Agilent, Vimta, Alfa Chemistry, Eurofins, Alera Labs, Impact Analytical, Leeder Analytical, Nelson Labs, Reading Scientific Services, Regis Technologies, Selvita, SGS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Impurity Analysis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical Impurity Analysis Service Market report?

Ans: The main players in the Pharmaceutical Impurity Analysis Service Market are Intertek, Creative Proteomics, Emery Pharma, Agilent, Vimta, Alfa Chemistry, Eurofins, Alera Labs, Impact Analytical, Leeder Analytical, Nelson Labs, Reading Scientific Services, Regis Technologies, Selvita, SGS

What are the Application segmentation covered in the Pharmaceutical Impurity Analysis Service Market report?

Ans: The Applications covered in the Pharmaceutical Impurity Analysis Service Market report are Pharmaceutical Industry, Agriculture, Biotechnology, Others

What are the Type segmentation covered in the Pharmaceutical Impurity Analysis Service Market report?

Ans: The Types covered in the Pharmaceutical Impurity Analysis Service Market report are Organic Impurity Analysis, Inorganic Impurity Analysis, Residual Solvent Analysis, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Organic Impurity Analysis

1.2.3 Inorganic Impurity Analysis

1.2.4 Residual Solvent Analysis

1.2.5 Others

1.3 Market by Application

1.3.1 Global Pharmaceutical Impurity Analysis Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Industry

1.3.3 Agriculture

1.3.4 Biotechnology

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical Impurity Analysis Service Market Perspective (2020-2031)

2.2 Global Pharmaceutical Impurity Analysis Service Growth Trends by Region

2.2.1 Global Pharmaceutical Impurity Analysis Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmaceutical Impurity Analysis Service Historic Market Size by Region (2020-2025)

2.2.3 Pharmaceutical Impurity Analysis Service Forecasted Market Size by Region (2026-2031)

2.3 Pharmaceutical Impurity Analysis Service Market Dynamics

2.3.1 Pharmaceutical Impurity Analysis Service Industry Trends

2.3.2 Pharmaceutical Impurity Analysis Service Market Drivers

2.3.3 Pharmaceutical Impurity Analysis Service Market Challenges

2.3.4 Pharmaceutical Impurity Analysis Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceutical Impurity Analysis Service Players by Revenue

3.1.1 Global Top Pharmaceutical Impurity Analysis Service Players by Revenue (2020-2025)

3.1.2 Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Players (2020-2025)

3.2 Global Pharmaceutical Impurity Analysis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmaceutical Impurity Analysis Service Revenue

3.4 Global Pharmaceutical Impurity Analysis Service Market Concentration Ratio

3.4.1 Global Pharmaceutical Impurity Analysis Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Impurity Analysis Service Revenue in 2024

3.5 Global Key Players of Pharmaceutical Impurity Analysis Service Head office and Area Served

3.6 Global Key Players of Pharmaceutical Impurity Analysis Service, Product and Application

3.7 Global Key Players of Pharmaceutical Impurity Analysis Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Impurity Analysis Service Breakdown Data by Type

4.1 Global Pharmaceutical Impurity Analysis Service Historic Market Size by Type (2020-2025)

4.2 Global Pharmaceutical Impurity Analysis Service Forecasted Market Size by Type (2026-2031)

5 Pharmaceutical Impurity Analysis Service Breakdown Data by Application

5.1 Global Pharmaceutical Impurity Analysis Service Historic Market Size by Application (2020-2025)

5.2 Global Pharmaceutical Impurity Analysis Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharmaceutical Impurity Analysis Service Market Size (2020-2031)

6.2 North America Pharmaceutical Impurity Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmaceutical Impurity Analysis Service Market Size by Country (2020-2025)

6.4 North America Pharmaceutical Impurity Analysis Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmaceutical Impurity Analysis Service Market Size (2020-2031)

7.2 Europe Pharmaceutical Impurity Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2020-2025)

7.4 Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size (2020-2031)

8.2 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pharmaceutical Impurity Analysis Service Market Size (2020-2031)

9.2 Latin America Pharmaceutical Impurity Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmaceutical Impurity Analysis Service Market Size by Country (2020-2025)

9.4 Latin America Pharmaceutical Impurity Analysis Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size (2020-2031)

10.2 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Intertek

11.1.1 Intertek Company Details

11.1.2 Intertek Business Overview

11.1.3 Intertek Pharmaceutical Impurity Analysis Service Introduction

11.1.4 Intertek Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.1.5 Intertek Recent Development

11.2 Creative Proteomics

11.2.1 Creative Proteomics Company Details

11.2.2 Creative Proteomics Business Overview

11.2.3 Creative Proteomics Pharmaceutical Impurity Analysis Service Introduction

11.2.4 Creative Proteomics Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.2.5 Creative Proteomics Recent Development

11.3 Emery Pharma

11.3.1 Emery Pharma Company Details

11.3.2 Emery Pharma Business Overview

11.3.3 Emery Pharma Pharmaceutical Impurity Analysis Service Introduction

11.3.4 Emery Pharma Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.3.5 Emery Pharma Recent Development

11.4 Agilent

11.4.1 Agilent Company Details

11.4.2 Agilent Business Overview

11.4.3 Agilent Pharmaceutical Impurity Analysis Service Introduction

11.4.4 Agilent Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.4.5 Agilent Recent Development

11.5 Vimta

11.5.1 Vimta Company Details

11.5.2 Vimta Business Overview

11.5.3 Vimta Pharmaceutical Impurity Analysis Service Introduction

11.5.4 Vimta Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.5.5 Vimta Recent Development

11.6 Alfa Chemistry

11.6.1 Alfa Chemistry Company Details

11.6.2 Alfa Chemistry Business Overview

11.6.3 Alfa Chemistry Pharmaceutical Impurity Analysis Service Introduction

11.6.4 Alfa Chemistry Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.6.5 Alfa Chemistry Recent Development

11.7 Eurofins

11.7.1 Eurofins Company Details

11.7.2 Eurofins Business Overview

11.7.3 Eurofins Pharmaceutical Impurity Analysis Service Introduction

11.7.4 Eurofins Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.7.5 Eurofins Recent Development

11.8 Alera Labs

11.8.1 Alera Labs Company Details

11.8.2 Alera Labs Business Overview

11.8.3 Alera Labs Pharmaceutical Impurity Analysis Service Introduction

11.8.4 Alera Labs Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.8.5 Alera Labs Recent Development

11.9 Impact Analytical

11.9.1 Impact Analytical Company Details

11.9.2 Impact Analytical Business Overview

11.9.3 Impact Analytical Pharmaceutical Impurity Analysis Service Introduction

11.9.4 Impact Analytical Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.9.5 Impact Analytical Recent Development

11.10 Leeder Analytical

11.10.1 Leeder Analytical Company Details

11.10.2 Leeder Analytical Business Overview

11.10.3 Leeder Analytical Pharmaceutical Impurity Analysis Service Introduction

11.10.4 Leeder Analytical Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.10.5 Leeder Analytical Recent Development

11.11 Nelson Labs

11.11.1 Nelson Labs Company Details

11.11.2 Nelson Labs Business Overview

11.11.3 Nelson Labs Pharmaceutical Impurity Analysis Service Introduction

11.11.4 Nelson Labs Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.11.5 Nelson Labs Recent Development

11.12 Reading Scientific Services

11.12.1 Reading Scientific Services Company Details

11.12.2 Reading Scientific Services Business Overview

11.12.3 Reading Scientific Services Pharmaceutical Impurity Analysis Service Introduction

11.12.4 Reading Scientific Services Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.12.5 Reading Scientific Services Recent Development

11.13 Regis Technologies

11.13.1 Regis Technologies Company Details

11.13.2 Regis Technologies Business Overview

11.13.3 Regis Technologies Pharmaceutical Impurity Analysis Service Introduction

11.13.4 Regis Technologies Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.13.5 Regis Technologies Recent Development

11.14 Selvita

11.14.1 Selvita Company Details

11.14.2 Selvita Business Overview

11.14.3 Selvita Pharmaceutical Impurity Analysis Service Introduction

11.14.4 Selvita Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.14.5 Selvita Recent Development

11.15 SGS

11.15.1 SGS Company Details

11.15.2 SGS Business Overview

11.15.3 SGS Pharmaceutical Impurity Analysis Service Introduction

11.15.4 SGS Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025)

11.15.5 SGS Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Reading Scientific Services

Regis Technologies

Selvita S.A

SGS Ltd

List of Tables

Table 1. Global Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Organic Impurity Analysis

Table 3. Key Players of Inorganic Impurity Analysis

Table 4. Key Players of Residual Solvent Analysis

Table 5. Key Players of Others

Table 6. Global Pharmaceutical Impurity Analysis Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Pharmaceutical Impurity Analysis Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Pharmaceutical Impurity Analysis Service Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Pharmaceutical Impurity Analysis Service Market Share by Region (2020-2025)

Table 10. Global Pharmaceutical Impurity Analysis Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Pharmaceutical Impurity Analysis Service Market Share by Region (2026-2031)

Table 12. Pharmaceutical Impurity Analysis Service Market Trends

Table 13. Pharmaceutical Impurity Analysis Service Market Drivers

Table 14. Pharmaceutical Impurity Analysis Service Market Challenges

Table 15. Pharmaceutical Impurity Analysis Service Market Restraints

Table 16. Global Pharmaceutical Impurity Analysis Service Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Pharmaceutical Impurity Analysis Service Market Share by Players (2020-2025)

Table 18. Global Top Pharmaceutical Impurity Analysis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Impurity Analysis Service as of 2024)

Table 19. Ranking of Global Top Pharmaceutical Impurity Analysis Service Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Pharmaceutical Impurity Analysis Service Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Pharmaceutical Impurity Analysis Service, Headquarters and Area Served

Table 22. Global Key Players of Pharmaceutical Impurity Analysis Service, Product and Application

Table 23. Global Key Players of Pharmaceutical Impurity Analysis Service, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Pharmaceutical Impurity Analysis Service Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Type (2020-2025)

Table 27. Global Pharmaceutical Impurity Analysis Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Type (2026-2031)

Table 29. Global Pharmaceutical Impurity Analysis Service Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Application (2020-2025)

Table 31. Global Pharmaceutical Impurity Analysis Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Pharmaceutical Impurity Analysis Service Revenue Market Share by Application (2026-2031)

Table 33. North America Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Pharmaceutical Impurity Analysis Service Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Pharmaceutical Impurity Analysis Service Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Pharmaceutical Impurity Analysis Service Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Pharmaceutical Impurity Analysis Service Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pharmaceutical Impurity Analysis Service Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size by Country (2026-2031) & (US$ Million)

Table 48. Intertek Company Details

Table 49. Intertek Business Overview

Table 50. Intertek Pharmaceutical Impurity Analysis Service Product

Table 51. Intertek Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 52. Intertek Recent Development

Table 53. Creative Proteomics Company Details

Table 54. Creative Proteomics Business Overview

Table 55. Creative Proteomics Pharmaceutical Impurity Analysis Service Product

Table 56. Creative Proteomics Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 57. Creative Proteomics Recent Development

Table 58. Emery Pharma Company Details

Table 59. Emery Pharma Business Overview

Table 60. Emery Pharma Pharmaceutical Impurity Analysis Service Product

Table 61. Emery Pharma Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 62. Emery Pharma Recent Development

Table 63. Agilent Company Details

Table 64. Agilent Business Overview

Table 65. Agilent Pharmaceutical Impurity Analysis Service Product

Table 66. Agilent Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 67. Agilent Recent Development

Table 68. Vimta Company Details

Table 69. Vimta Business Overview

Table 70. Vimta Pharmaceutical Impurity Analysis Service Product

Table 71. Vimta Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 72. Vimta Recent Development

Table 73. Alfa Chemistry Company Details

Table 74. Alfa Chemistry Business Overview

Table 75. Alfa Chemistry Pharmaceutical Impurity Analysis Service Product

Table 76. Alfa Chemistry Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 77. Alfa Chemistry Recent Development

Table 78. Eurofins Company Details

Table 79. Eurofins Business Overview

Table 80. Eurofins Pharmaceutical Impurity Analysis Service Product

Table 81. Eurofins Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 82. Eurofins Recent Development

Table 83. Alera Labs Company Details

Table 84. Alera Labs Business Overview

Table 85. Alera Labs Pharmaceutical Impurity Analysis Service Product

Table 86. Alera Labs Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 87. Alera Labs Recent Development

Table 88. Impact Analytical Company Details

Table 89. Impact Analytical Business Overview

Table 90. Impact Analytical Pharmaceutical Impurity Analysis Service Product

Table 91. Impact Analytical Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 92. Impact Analytical Recent Development

Table 93. Leeder Analytical Company Details

Table 94. Leeder Analytical Business Overview

Table 95. Leeder Analytical Pharmaceutical Impurity Analysis Service Product

Table 96. Leeder Analytical Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 97. Leeder Analytical Recent Development

Table 98. Nelson Labs Company Details

Table 99. Nelson Labs Business Overview

Table 100. Nelson Labs Pharmaceutical Impurity Analysis Service Product

Table 101. Nelson Labs Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 102. Nelson Labs Recent Development

Table 103. Reading Scientific Services Company Details

Table 104. Reading Scientific Services Business Overview

Table 105. Reading Scientific Services Pharmaceutical Impurity Analysis Service Product

Table 106. Reading Scientific Services Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 107. Reading Scientific Services Recent Development

Table 108. Regis Technologies Company Details

Table 109. Regis Technologies Business Overview

Table 110. Regis Technologies Pharmaceutical Impurity Analysis Service Product

Table 111. Regis Technologies Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 112. Regis Technologies Recent Development

Table 113. Selvita Company Details

Table 114. Selvita Business Overview

Table 115. Selvita Pharmaceutical Impurity Analysis Service Product

Table 116. Selvita Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 117. Selvita Recent Development

Table 118. SGS Company Details

Table 119. SGS Business Overview

Table 120. SGS Pharmaceutical Impurity Analysis Service Product

Table 121. SGS Revenue in Pharmaceutical Impurity Analysis Service Business (2020-2025) & (US$ Million)

Table 122. SGS Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Pharmaceutical Impurity Analysis Service Picture

Figure 2. Global Pharmaceutical Impurity Analysis Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmaceutical Impurity Analysis Service Market Share by Type: 2024 VS 2031

Figure 4. Organic Impurity Analysis Features

Figure 5. Inorganic Impurity Analysis Features

Figure 6. Residual Solvent Analysis Features

Figure 7. Others Features

Figure 8. Global Pharmaceutical Impurity Analysis Service Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Pharmaceutical Impurity Analysis Service Market Share by Application: 2024 VS 2031

Figure 10. Pharmaceutical Industry Case Studies

Figure 11. Agriculture Case Studies

Figure 12. Biotechnology Case Studies

Figure 13. Others Case Studies

Figure 14. Pharmaceutical Impurity Analysis Service Report Years Considered

Figure 15. Global Pharmaceutical Impurity Analysis Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Pharmaceutical Impurity Analysis Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Pharmaceutical Impurity Analysis Service Market Share by Region: 2024 VS 2031

Figure 18. Global Pharmaceutical Impurity Analysis Service Market Share by Players in 2024

Figure 19. Global Top Pharmaceutical Impurity Analysis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Impurity Analysis Service as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Pharmaceutical Impurity Analysis Service Revenue in 2024

Figure 21. North America Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Pharmaceutical Impurity Analysis Service Market Share by Country (2020-2031)

Figure 23. United States Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Pharmaceutical Impurity Analysis Service Market Share by Country (2020-2031)

Figure 27. Germany Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Pharmaceutical Impurity Analysis Service Market Share by Region (2020-2031)

Figure 35. China Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Pharmaceutical Impurity Analysis Service Market Share by Country (2020-2031)

Figure 43. Mexico Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Pharmaceutical Impurity Analysis Service Market Share by Country (2020-2031)

Figure 47. Turkey Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Pharmaceutical Impurity Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Intertek Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 51. Creative Proteomics Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 52. Emery Pharma Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 53. Agilent Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 54. Vimta Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 55. Alfa Chemistry Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 56. Eurofins Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 57. Alera Labs Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 58. Impact Analytical Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 59. Leeder Analytical Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 60. Nelson Labs Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 61. Reading Scientific Services Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 62. Regis Technologies Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 63. Selvita Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 64. SGS Revenue Growth Rate in Pharmaceutical Impurity Analysis Service Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions